Skip to main content
Top
Published in: Supportive Care in Cancer 12/2015

01-12-2015 | Letter to the editor

Response to editorial by Richard Crevenna, MD, regarding “cancer rehabilitation and palliative care: critical components in the delivery of high-quality oncology services” by Silver et al.

Authors: Julie K. Silver, Sean R. Smith, Eric M. Wisotzky, Vishwa S. Raj, Jack B. Fu, Rebecca A. Kirch

Published in: Supportive Care in Cancer | Issue 12/2015

Login to get access

Excerpt

Richard Crevenna, MD, provided insightful comments in his editorial response to our article entitled “Cancer Rehabilitation and Palliative Care: Critical Components in the Delivery of High-Quality Oncology Services” [1]. We were impressed by Dr. Crevenna’s description of the recent initiatives in interdisciplinary care, particularly in symptom management, at the Comprehensive Cancer Centre of the Medical University of Vienna. Notable were the inclusion of a rehabilitation tumor board and the integration of rehabilitation services into a clinic dedicated to symptom management which extends beyond issues typically associated with rehabilitation (e.g., mucositis and nausea). We believe that this type of interdisciplinary collaboration is critical to the success of well-designed cancer rehabilitation programs. …
Literature
1.
go back to reference Silver JK, Raj VS, Fu JB, Wisotzky EM, Smith SR, Kirch RA (2015) Cancer rehabilitation and palliative care: critical components in the delivery of high-quality oncology services. Support Care Cancer. (in press) Silver JK, Raj VS, Fu JB, Wisotzky EM, Smith SR, Kirch RA (2015) Cancer rehabilitation and palliative care: critical components in the delivery of high-quality oncology services. Support Care Cancer. (in press)
Metadata
Title
Response to editorial by Richard Crevenna, MD, regarding “cancer rehabilitation and palliative care: critical components in the delivery of high-quality oncology services” by Silver et al.
Authors
Julie K. Silver
Sean R. Smith
Eric M. Wisotzky
Vishwa S. Raj
Jack B. Fu
Rebecca A. Kirch
Publication date
01-12-2015
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 12/2015
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2917-0

Other articles of this Issue 12/2015

Supportive Care in Cancer 12/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine